Cow's milk allergy in multiple sclerosis patients

Fereshteh Ashtari1, Fatemeh Jamshidi, Raheleh Shokouhi Shoormasti

  • 1Department of Neurology, Isfahan Neuroscience Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

Abstract

Insights

This study found no significant difference in cow's milk allergy (CMA) between multiple sclerosis (MS) patients and healthy individuals. Further research is needed to understand environmental factors in MS development.

Area of Science:

  • Neurology
  • Immunology
  • Environmental Health

Background:

  • Environmental factors like nutrition and allergens may influence multiple sclerosis (MS) development.
  • Cow's milk allergy (CMA) is a potential environmental factor under investigation.
  • This study aimed to compare CMA prevalence in MS patients versus healthy controls.

Purpose of the Study:

  • To evaluate the frequency of cow's milk allergy (CMA) in patients with multiple sclerosis (MS).
  • To compare the prevalence of CMA in MS patients against a healthy control group.

Main Methods:

  • A cohort of 48 MS patients was compared with 48 healthy subjects.
  • Cow's milk specific immunoglobulin E (IgE) levels were measured using Immuno CAP.
  • Chi-square test was used to compare sex and CMA frequency between groups.

Main Results:

  • No cow's milk specific IgE was detected in the serum of either MS patients or healthy controls.
  • The study included 96 subjects (22% male, 78% female) with a mean age of 30.8 ± 6.6 years.
  • No statistically significant difference in CMA was observed between the MS and control groups (P value = 0.83).

Conclusions:

  • There is no discernible difference in cow's milk allergy between individuals with multiple sclerosis and healthy subjects.
  • The findings suggest CMA is not a differentiating factor between MS patients and controls in this cohort.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Allergic Reactions02:06

Allergic Reactions

Overview
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...